Reductive Amination in the Synthesis of Pharmaceuticals
Oleg I. Afanasyev, Ekaterina A. Kuchuk, Dmitry L. Usanov, Denis Alexandrovich Chusov
Russian Academy of Sciences A. N. Nesmeyanov Institute of Organoelement Compounds Broad Institute National Research University Higher School of Economics
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Reductive amination plays a paramount role in pharmaceutical and medicinal chemistry owing to its synthetic merits and the ubiquitous presence of amines among biologically active compounds. It is one of the key approaches to C-N bond construction due to its operational easiness and a wide toolbox of protocols. Recent studies show that at least a quarter of C-N bond-forming reactions in the pharmaceutical industry are performed via reductive amination. This Review concisely compiles information on 71 medical substances that are synthesized by reductive amination. Compounds are grouped according to the principle of action, which includes drugs affecting the central nervous system, drugs affecting the cardiovascular system, anticancer drugs, antibiotics, antiviral and antifungal medicines, drugs affecting the urinary system, drugs affecting the respiratory system, antidiabetic medications, drugs affecting the gastrointestinal tract, and drugs regulating metabolic processes. A general synthetic scheme is provided for each compound, and the description is focused on reductive amination steps. The green chemistry metric of reaction mass efficiency was calculated for all reactions.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
化学Advanced Synthetic Organic Chemistry
Synthesis and Catalytic Reactions · Asymmetric Hydrogenation and Catalysis
参考文献 272
此处列出前 3 条
引用本文 814
按被引量排序,此处列出前 3 条